Details
Stereochemistry | ACHIRAL |
Molecular Formula | 2C2H5NO2.Fe.O4S |
Molecular Weight | 302.041 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Fe++].NCC(O)=O.NCC(O)=O.[O-]S([O-])(=O)=O
InChI
InChIKey=YJYOLOWXCPIBSY-UHFFFAOYSA-L
InChI=1S/2C2H5NO2.Fe.H2O4S/c2*3-1-2(4)5;;1-5(2,3)4/h2*1,3H2,(H,4,5);;(H2,1,2,3,4)/q;;+2;/p-2
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/14116934http://www.foodchemadditives.com/products/Ferrous-Lactatehttp://nj.gov/health/eoh/rtkweb/documents/fs/0928.pdfDOI: 10.1021/ja00949a016 Retrived from http://pubs.acs.org/doi/abs/10.1021/ja00949a016https://www.drugs.com/inactive/ferrous-oxide-389.htmlhttp://www.druglead.com/cds/ferrous-iodide.htmlhttp://www.drugfuture.com/chemdata/ferroglycine-sulfate.htmlhttps://www.ncbi.nlm.nih.gov/pubmed/16694502Curator's Comment: description was created based on several sources, including
http://www.minapharm.com/Public/ProductDetails.aspx?ProductCode=FERRO_SANO&langParam=en
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14116934http://www.foodchemadditives.com/products/Ferrous-Lactatehttp://nj.gov/health/eoh/rtkweb/documents/fs/0928.pdfDOI: 10.1021/ja00949a016 Retrived from http://pubs.acs.org/doi/abs/10.1021/ja00949a016https://www.drugs.com/inactive/ferrous-oxide-389.htmlhttp://www.druglead.com/cds/ferrous-iodide.htmlhttp://www.drugfuture.com/chemdata/ferroglycine-sulfate.htmlhttps://www.ncbi.nlm.nih.gov/pubmed/16694502
Curator's Comment: description was created based on several sources, including
http://www.minapharm.com/Public/ProductDetails.aspx?ProductCode=FERRO_SANO&langParam=en
Iron(II) gluconate (also known as a ferrous gluconate) is used in the treatment of hypochromic anemia. The real problem of iron therapy is not the theoretical utilization of iron, or the reticulocyte response, or even the daily increase of hemoglobin. These are important only as they indicate the return of the patients' blood to normal in a reasonably short time without undue inconvenience. Most patients suffering from hypochromic anemia respond well to most forms of iron when administered in adequate dosage. For the patients who cannot tolerate the usual iron compounds, it is important to have a medication which is effective and which causes minimum disturbance. Ferrous gluconate is such a medicament.
Originator
Approval Year
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Palliative | Unknown Approved UseUnknown |
|||
Palliative | Unknown Approved UseUnknown |
|||
Primary | Ferro Sanol Duodenal Approved UseFerro Sanol is an iron substitute in case of latent or manifest iron deficiency with and without development of anaemia. |
|||
PubMed
Title | Date | PubMed |
---|---|---|
FERROUS IODIDE AS A SUBSTITUTE FOR VITAMIN A IN RATS. | 1932 Jul 1 |
|
[FERROUS ASPARTATE IN THERAPY]. | 1964 Jan 1 |
|
Reversal of multidrug resistance by magnetic Fe3O4 nanoparticle copolymerizating daunorubicin and 5-bromotetrandrine in xenograft nude-mice. | 2009 |
|
Bioleaching of heavy metals from sewage sludge by indigenous iron-oxidizing microorganisms using ammonium ferrous sulfate and ferrous sulfate as energy sources: a comparative study. | 2009 Nov 15 |
|
Reactivity enhancement of iron sulfide nanoparticles stabilized by sodium alginate: Taking Cr (VI) removal as an example. | 2017 Jul 5 |
|
Atomic Layer Deposition of Iron Sulfide and Its Application as a Catalyst in the Hydrogenation of Azobenzenes. | 2017 Mar 13 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugs.com/ppa/ferrous-salts.html
Unknown
Route of Administration:
Oral
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
B03AA01
Created by
admin on Sat Dec 16 02:10:52 GMT 2023 , Edited by admin on Sat Dec 16 02:10:52 GMT 2023
|
||
|
WHO-VATC |
QB03AA01
Created by
admin on Sat Dec 16 02:10:52 GMT 2023 , Edited by admin on Sat Dec 16 02:10:52 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
238-784-3
Created by
admin on Sat Dec 16 02:10:52 GMT 2023 , Edited by admin on Sat Dec 16 02:10:52 GMT 2023
|
PRIMARY | |||
|
DB14501
Created by
admin on Sat Dec 16 02:10:52 GMT 2023 , Edited by admin on Sat Dec 16 02:10:52 GMT 2023
|
PRIMARY | |||
|
167159
Created by
admin on Sat Dec 16 02:10:52 GMT 2023 , Edited by admin on Sat Dec 16 02:10:52 GMT 2023
|
PRIMARY | |||
|
105655
Created by
admin on Sat Dec 16 02:10:52 GMT 2023 , Edited by admin on Sat Dec 16 02:10:52 GMT 2023
|
PRIMARY | RxNorm | ||
|
56PS9HY5XI
Created by
admin on Sat Dec 16 02:10:52 GMT 2023 , Edited by admin on Sat Dec 16 02:10:52 GMT 2023
|
PRIMARY | |||
|
DTXSID20933088
Created by
admin on Sat Dec 16 02:10:52 GMT 2023 , Edited by admin on Sat Dec 16 02:10:52 GMT 2023
|
PRIMARY | |||
|
CHEMBL3707208
Created by
admin on Sat Dec 16 02:10:52 GMT 2023 , Edited by admin on Sat Dec 16 02:10:52 GMT 2023
|
PRIMARY | |||
|
SUB26615
Created by
admin on Sat Dec 16 02:10:52 GMT 2023 , Edited by admin on Sat Dec 16 02:10:52 GMT 2023
|
PRIMARY | |||
|
14729-84-1
Created by
admin on Sat Dec 16 02:10:52 GMT 2023 , Edited by admin on Sat Dec 16 02:10:52 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD